Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_assertion type Assertion NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_head.
- NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_assertion description "[We investigated the effect of a concomitant treatment of ICI 164384 and B-interferon (beta-IFN) on the growth of estrogen-receptor-positive (ER+) and estrogen-receptor-negative (ER-) breast cancer cell lines and on their steroid receptor profiles.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_provenance.
- NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_assertion evidence source_evidence_literature NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_provenance.
- NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_assertion SIO_000772 8669823 NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_provenance.
- NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_assertion wasDerivedFrom befree-2016 NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_provenance.
- NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_assertion wasGeneratedBy ECO_0000203 NP1352145.RAVNYn_x8Fy_b3z6UN3_MH9DR_3e4lttEKw_IEF1L636o130_provenance.